JP2012500010A5 - - Google Patents

Download PDF

Info

Publication number
JP2012500010A5
JP2012500010A5 JP2011523265A JP2011523265A JP2012500010A5 JP 2012500010 A5 JP2012500010 A5 JP 2012500010A5 JP 2011523265 A JP2011523265 A JP 2011523265A JP 2011523265 A JP2011523265 A JP 2011523265A JP 2012500010 A5 JP2012500010 A5 JP 2012500010A5
Authority
JP
Japan
Prior art keywords
hsp
tissue
beta
cell
binding agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011523265A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012500010A (ja
JP5826629B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2009/001060 external-priority patent/WO2010019997A1/en
Publication of JP2012500010A publication Critical patent/JP2012500010A/ja
Publication of JP2012500010A5 publication Critical patent/JP2012500010A5/ja
Application granted granted Critical
Publication of JP5826629B2 publication Critical patent/JP5826629B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011523265A 2008-08-18 2009-08-18 モノクローナル抗体ｓｔｒｏ−４ Active JP5826629B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18934908P 2008-08-18 2008-08-18
US61/189,349 2008-08-18
PCT/AU2009/001060 WO2010019997A1 (en) 2008-08-18 2009-08-18 Monoclonal antibody stro-4

Publications (3)

Publication Number Publication Date
JP2012500010A JP2012500010A (ja) 2012-01-05
JP2012500010A5 true JP2012500010A5 (https=) 2012-09-27
JP5826629B2 JP5826629B2 (ja) 2015-12-02

Family

ID=41706760

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011523265A Active JP5826629B2 (ja) 2008-08-18 2009-08-18 モノクローナル抗体ｓｔｒｏ−４

Country Status (11)

Country Link
US (2) US9090678B2 (https=)
EP (2) EP3121597A1 (https=)
JP (1) JP5826629B2 (https=)
KR (1) KR101713343B1 (https=)
CN (3) CN102257388B (https=)
AU (2) AU2009284692B2 (https=)
CA (1) CA2734210C (https=)
ES (1) ES2707274T3 (https=)
SG (1) SG10201601279SA (https=)
TR (1) TR201900975T4 (https=)
WO (1) WO2010019997A1 (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2011129379A1 (ja) * 2010-04-13 2013-07-18 独立行政法人理化学研究所 新規抗ｈｓｐ９０モノクローナル抗体
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
GB201011173D0 (en) 2010-07-02 2010-08-18 Smith & Nephew Provision of wound filler
WO2012048276A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
JP6078472B2 (ja) 2010-11-25 2017-02-08 スミス アンド ネフュー ピーエルシーＳｍｉｔｈ ＆ Ｎｅｐｈｅｗ Ｐｕｂｌｉｃ Ｌｉｍｉｔｅｄ Ｃｏｍｐａｎｙ 組成物ｉ−ｉｉおよび生成物ならびにそれらの使用
GB201020005D0 (en) 2010-11-25 2011-01-12 Smith & Nephew Composition 1-1
AU2012262675B2 (en) * 2011-06-03 2016-05-19 Mesoblast, Inc Methods of treating or preventing neurological diseases
CN104508124B (zh) 2011-07-06 2017-11-17 细胞治疗有限公司 中胚层谱系祖细胞
US20150159066A1 (en) 2011-11-25 2015-06-11 Smith & Nephew Plc Composition, apparatus, kit and method and uses thereof
US20160120706A1 (en) 2013-03-15 2016-05-05 Smith & Nephew Plc Wound dressing sealant and use thereof
EP2968647B1 (en) 2013-03-15 2022-06-29 Smith & Nephew plc Wound dressing sealant and use thereof
US20150037436A1 (en) 2013-07-30 2015-02-05 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
WO2015073913A1 (en) 2013-11-16 2015-05-21 Terumo Bct, Inc. Expanding cells in a bioreactor
WO2015148704A1 (en) 2014-03-25 2015-10-01 Terumo Bct, Inc. Passive replacement of media
EP3198006B1 (en) 2014-09-26 2021-03-24 Terumo BCT, Inc. Scheduled feed
CA2986702C (en) 2015-05-21 2023-04-04 David Wang Modified demineralized cortical bone fibers
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US10912864B2 (en) 2015-07-24 2021-02-09 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
CN117247899A (zh) 2017-03-31 2023-12-19 泰尔茂比司特公司 细胞扩增
CN110684105B (zh) * 2019-09-11 2021-01-29 江苏莱森生物科技研究院有限公司 一种抗hsp90单克隆抗体及试剂盒
EP4314244B1 (en) 2021-03-23 2025-07-23 Terumo BCT, Inc. Cell capture and expansion
US12209689B2 (en) 2022-02-28 2025-01-28 Terumo Kabushiki Kaisha Multiple-tube pinch valve assembly
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622871A (en) 1987-04-27 1997-04-22 Unilever Patent Holdings B.V. Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
US1457499A (en) 1921-03-12 1923-06-05 Bethlehem Steel Corp Drill shank
US3089815A (en) 1951-10-11 1963-05-14 Lieb Hans Injectable pharmaceutical preparation, and a method of making same
US4554101A (en) 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4983393A (en) 1987-07-21 1991-01-08 Maximed Corporation Intra-vaginal device and method for sustained drug release
US5173414A (en) 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
US5837539A (en) 1990-11-16 1998-11-17 Osiris Therapeutics, Inc. Monoclonal antibodies for human mesenchymal stem cells
US5226914A (en) 1990-11-16 1993-07-13 Caplan Arnold I Method for treating connective tissue disorders
AU4543193A (en) 1992-06-22 1994-01-24 Henry E. Young Scar inhibitory factor and use thereof
US5834256A (en) 1993-06-11 1998-11-10 Cell Genesys, Inc. Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
US5591625A (en) 1993-11-24 1997-01-07 Case Western Reserve University Transduced mesenchymal stem cells
US5693531A (en) 1993-11-24 1997-12-02 The United States Of America As Represented By The Department Of Health And Human Services Vector systems for the generation of adeno-associated virus particles
EP0748215B1 (en) 1994-02-17 2003-05-28 New York Blood Center, Inc. Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use
US7252989B1 (en) 1994-04-04 2007-08-07 Board Of Regents, The University Of Texas System Adenovirus supervector system
JP4223548B2 (ja) 1994-12-07 2009-02-12 ジ・アメリカン・ナショナル・レッド・クロス 補足または非補足組織シーラント、それらの製法および使用
US5643192A (en) 1995-04-06 1997-07-01 Hamilton Civic Hospitals Research Development, Inc. Autologous fibrin glue and methods for its preparation and use
WO1997021824A2 (en) 1995-12-15 1997-06-19 Systemix, Inc. Method for obtaining retroviral vector supernatant having high transduction efficiency
US5910434A (en) 1995-12-15 1999-06-08 Systemix, Inc. Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant
WO2001097872A1 (en) 2000-06-22 2001-12-27 Austin Sam L Bioadhesive compositions and methods of preparation and use
EP1457499A1 (en) * 2003-03-12 2004-09-15 Tufts University School Of Medicine Inhibitors of extracellular Hsp90
AU2004252828A1 (en) * 2003-06-04 2005-01-06 The Trustees Of The University Of Pennsylvania NDMA scalable archive hardware/software architecture for load balancing, independent processing, and querying of records
US20070178537A1 (en) * 2003-06-30 2007-08-02 Sloan-Kettering Institute For Cancer Research Assays for detection of bioactive compounds that interact with heat shock protein 90
JP2007530420A (ja) * 2003-07-07 2007-11-01 ザ・ジェネラル・ホスピタル・コーポレイション ｆｕｇｅｔａｃｔｉｃタンパク質、組成物および使用方法
CN1640887A (zh) * 2004-01-08 2005-07-20 北京中天康泰生物科技有限公司 一种用于生物治疗的“热休克蛋白专用提取盒”
CA2572318A1 (en) * 2004-07-02 2006-01-12 Neutec Pharma Plc Treatment of cancer
ES2313805B1 (es) * 2004-10-04 2009-12-23 Cellerix, S.L. Identificacion y aislamiento de celulas multipotentes de tejido mesenquimal no osteocondral.
CN101506355B (zh) * 2004-09-24 2012-06-27 成血管细胞系统公司 多能扩增间充质前体细胞子代（memp）及其应用
WO2006050333A2 (en) * 2004-11-02 2006-05-11 The Regents Of The University Of California Methods and compositions for modulating apoptosis
JP4929447B2 (ja) * 2005-05-16 2012-05-09 国立大学法人北海道大学 間葉系幹細胞から軟骨細胞を調製する方法
CA2640794C (en) 2006-02-16 2015-04-14 Universite Libre De Bruxelles A method for osteogenic differentiation of bone marrow stem cells (bmsc) and uses thereof
WO2014160954A1 (en) 2013-03-28 2014-10-02 Level 3 Communications, Llc System and method for network provisioning

Similar Documents

Publication Publication Date Title
JP2012500010A5 (https=)
JP5826629B2 (ja) モノクローナル抗体ｓｔｒｏ−４
Lecourt et al. Characterization of distinct mesenchymal-like cell populations from human skeletal muscle in situ and in vitro
KR20040039382A (ko) 골격근 간질 유래 다분화능 줄기세포
Conrad et al. GATA transcription in a small rhodamine 123lowCD34+ subpopulation of a peripheral blood–derived CD34− CD105+ mesenchymal cell line
Chang et al. Umbilical cord Wharton’s jelly repeated culture system: a new device and method for obtaining abundant mesenchymal stem cells for bone tissue engineering
Yo et al. Fucci-guided purification of hematopoietic stem cells with high repopulating activity
US20150238532A1 (en) Methods to isolate human mesenchymal stem cells
Yokota et al. Markers for hematopoietic stem cells: histories and recent achievements
EP1539822B1 (de) Antikörper zur isolierung und/oder identifizierung mesenchymaler stammzellen und verfahren zur isolierung und/oder identifizierung mesenchymaler stammzellen
JPWO2018207918A1 (ja) 移植効率を向上させる間葉系幹細胞の純化方法
EP2828663B1 (de) Neue msc-oberflächenmarker
CN119409826B (zh) 识别猪肝脏间充质干细胞的单克隆抗体及杂交瘤细胞株plm1
Bunting et al. The tao of hematopoietic stem cells: toward a unified theory of tissue regeneration
Togoo et al. Alpha-smooth muscle actin expression identifies subpopulations of mouse lymph node non-hematopoietic cells
DE19927306A1 (de) Ein GPI-verankertes Antigen auf Zelloberflächen von Fibroblasten und mesenchymalen Stammzellen, seine Verwendung zur Gewinnung von monoklonalen Antikörpern und darauf aufbauende Testkite
Szepesi et al. Research Article In Vitro Characterization of Human Mesenchymal Stem Cells Isolated from Different Tissues with a Potential to Promote Complex Bone Regeneration
Obach-Schröck Bone marrow-derived multipotent mesenchymal stromal cells from horses after euthanasia
Biziulevičienė et al. Investigation of unmatured hematopoietic cell migration in a mouse model